516 related articles for article (PubMed ID: 34582788)
1. In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target.
Wang X; Tokheim C; Gu SS; Wang B; Tang Q; Li Y; Traugh N; Zeng Z; Zhang Y; Li Z; Zhang B; Fu J; Xiao T; Li W; Meyer CA; Chu J; Jiang P; Cejas P; Lim K; Long H; Brown M; Liu XS
Cell; 2021 Oct; 184(21):5357-5374.e22. PubMed ID: 34582788
[TBL] [Abstract][Full Text] [Related]
2. Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.
Sarkar TR; Sharan S; Wang J; Pawar SA; Cantwell CA; Johnson PF; Morrison DK; Wang JM; Sterneck E
Mol Cell Biol; 2012 Jan; 32(2):320-32. PubMed ID: 22037769
[TBL] [Abstract][Full Text] [Related]
3. In vivo multidimensional CRISPR screens identify
Ji P; Gong Y; Jin ML; Wu HL; Guo LW; Pei YC; Chai WJ; Jiang YZ; Liu Y; Ma XY; Di GH; Hu X; Shao ZM
Sci Adv; 2022 Jul; 8(26):eabl8247. PubMed ID: 35767614
[TBL] [Abstract][Full Text] [Related]
4. Computational Discovery of Cancer Immunotherapy Targets by Intercellular CRISPR Screens.
Yim S; Hwang W; Han N; Lee D
Front Immunol; 2022; 13():884561. PubMed ID: 35651625
[TBL] [Abstract][Full Text] [Related]
5. E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1.
Li DQ; Ohshiro K; Reddy SD; Pakala SB; Lee MH; Zhang Y; Rayala SK; Kumar R
Proc Natl Acad Sci U S A; 2009 Oct; 106(41):17493-8. PubMed ID: 19805145
[TBL] [Abstract][Full Text] [Related]
6. The SIAH2-NRF1 axis spatially regulates tumor microenvironment remodeling for tumor progression.
Ma B; Cheng H; Mu C; Geng G; Zhao T; Luo Q; Ma K; Chang R; Liu Q; Gao R; Nie J; Xie J; Han J; Chen L; Ma G; Zhu Y; Chen Q
Nat Commun; 2019 Mar; 10(1):1034. PubMed ID: 30833558
[TBL] [Abstract][Full Text] [Related]
7.
Guo X; Mahlakõiv T; Ye Q; Somanchi S; He S; Rana H; DiFiglia A; Gleason J; van der Touw W; Hariri R; Zhang X
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33741730
[TBL] [Abstract][Full Text] [Related]
8. IP
Lin H; Yan Y; Luo Y; So WY; Wei X; Zhang X; Yang X; Zhang J; Su Y; Yang X; Zhang B; Zhang K; Jiang N; Chow BKC; Han W; Wang F; Rao F
Nat Commun; 2021 Apr; 12(1):2461. PubMed ID: 33911083
[TBL] [Abstract][Full Text] [Related]
9. A novel histone deacetylase inhibitor TMU-35435 enhances etoposide cytotoxicity through the proteasomal degradation of DNA-PKcs in triple-negative breast cancer.
Wu YH; Hong CW; Wang YC; Huang WJ; Yeh YL; Wang BJ; Wang YJ; Chiu HW
Cancer Lett; 2017 Aug; 400():79-88. PubMed ID: 28450160
[TBL] [Abstract][Full Text] [Related]
10. E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer.
Liao L; Song M; Li X; Tang L; Zhang T; Zhang L; Pan Y; Chouchane L; Ma X
Cancer Res; 2017 Apr; 77(8):2090-2101. PubMed ID: 28330927
[TBL] [Abstract][Full Text] [Related]
11. COP1 functions as a FoxO1 ubiquitin E3 ligase to regulate FoxO1-mediated gene expression.
Kato S; Ding J; Pisck E; Jhala US; Du K
J Biol Chem; 2008 Dec; 283(51):35464-73. PubMed ID: 18815134
[TBL] [Abstract][Full Text] [Related]
12. The E3 ligase COP1 promotes ERα signaling and suppresses EMT in breast cancer.
Tang SC; Lion Q; Peulen O; Chariot P; Lavergne A; Mayer A; Fuster PA; Close P; Klein S; Florin A; Büttner R; Nemazanyy I; Shostak K; Chariot A
Oncogene; 2022 Jan; 41(2):173-190. PubMed ID: 34716429
[TBL] [Abstract][Full Text] [Related]
13. Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer.
Cao X; Li B; Chen J; Dang J; Chen S; Gunes EG; Xu B; Tian L; Muend S; Raoof M; Querfeld C; Yu J; Rosen ST; Wang Y; Feng M
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33753567
[TBL] [Abstract][Full Text] [Related]
14. COP1 targets C/EBPα for degradation and induces acute myeloid leukemia via Trib1.
Yoshida A; Kato JY; Nakamae I; Yoneda-Kato N
Blood; 2013 Sep; 122(10):1750-60. PubMed ID: 23884858
[TBL] [Abstract][Full Text] [Related]
15. Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice.
Migliorini D; Bogaerts S; Defever D; Vyas R; Denecker G; Radaelli E; Zwolinska A; Depaepe V; Hochepied T; Skarnes WC; Marine JC
J Clin Invest; 2011 Apr; 121(4):1329-43. PubMed ID: 21403399
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade.
Qin Y; Vasilatos SN; Chen L; Wu H; Cao Z; Fu Y; Huang M; Vlad AM; Lu B; Oesterreich S; Davidson NE; Huang Y
Oncogene; 2019 Jan; 38(3):390-405. PubMed ID: 30111819
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin ligase COP1 is a critical negative regulator of p53.
Dornan D; Wertz I; Shimizu H; Arnott D; Frantz GD; Dowd P; O'Rourke K; Koeppen H; Dixit VM
Nature; 2004 May; 429(6987):86-92. PubMed ID: 15103385
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin Ligase COP1 Controls Hepatic Fat Metabolism by Targeting ATGL for Degradation.
Ghosh M; Niyogi S; Bhattacharyya M; Adak M; Nayak DK; Chakrabarti S; Chakrabarti P
Diabetes; 2016 Dec; 65(12):3561-3572. PubMed ID: 27658392
[TBL] [Abstract][Full Text] [Related]
19. Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade.
Bai X; Zhou Y; Yokota Y; Matsumoto Y; Zhai B; Maarouf N; Hayashi H; Carlson R; Zhang S; Sousa A; Sun B; Ghanbari H; Dong X; Wands JR
J Exp Clin Cancer Res; 2022 Apr; 41(1):132. PubMed ID: 35392977
[TBL] [Abstract][Full Text] [Related]
20. An Arabidopsis SUMO E3 Ligase, SIZ1, Negatively Regulates Photomorphogenesis by Promoting COP1 Activity.
Lin XL; Niu D; Hu ZL; Kim DH; Jin YH; Cai B; Liu P; Miura K; Yun DJ; Kim WY; Lin R; Jin JB
PLoS Genet; 2016 Apr; 12(4):e1006016. PubMed ID: 27128446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
